However, miR-200a-5p has the opposite effect in breast cancers as suppresses cell proliferation by regulating the expression of hepatocyte growth factor (MET) and epidermal growth factor receptor (EGFR) [45]. The gene discussed is HGF; the disease is breast cancer.